% Expired Patents = 50.0

EPO Patents = 5

Forward Citations = 136

Loading Chart...

4 inventors (with patents filed for the assignee):

Pierre Hilaire (4 out of 6 patents)

Machiel Van Der Leest (3 out of 10 patents)

James J Leary (1 out of 17 patents)

4. Machiel Van De Leest (1 out of 1 patent)

5. Laurence Theron (1 out of 2 patents)

6. Lydie Pasquier (1 patent)

7. Olivier Berc (0 patent)

8. Philippe Moulin (0 patent)

4 patents: Sort by Forward Citations

1. 9278015 - Catheter system for stenting and drug treatment of bifurcated vessels (2016-03-08),

2. 8814925 - Apparatus and methods for stent delivery with embolic protection (2014-08-26),

3. 8808359 - Catheter system for stenting bifurcated vessels (2014-08-19),

4. 7645296 - Catheter system for protected angioplasty and stenting at a carotid bifurcation (2010-01-12),

Company Overview

Minvasys is a global medical device company that specializes in providing innovative solutions for peripheral vascular interventions. With a focus on improving patient outcomes and quality of life, Minvasys offers a range of cutting-edge products for use in interventional cardiology and vascular surgery. The company is committed to advancing the field of vascular medicine through research, development, and collaboration with healthcare professionals.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#15 in Gennevilliers

#3,356 in France

Gennevilliers, France

Minvasys

Forward Citations = 136

4 inventors:

Pierre Hilaire (4 out of 6 patents)

Machiel Van Der Leest (3 out of 10 patents)

James J Leary (1 out of 17 patents)

4. Machiel Van De Leest (1 out of 1 patent)

5. Laurence Theron (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Minvasys. Retrieved from https://idiyas.com/company/minvasys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]